EUVIMEDEUVIMED entdecken
Crossref

Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides

Yichen Tong iD, Wentao Zhu iD, Jian Chen, Wenqian Zhang, Fang Xu iD, Jiyan Pang iD

Journal of Medicinal Chemistry · 14.09.2023 · 66 (17) · 12614-12628

DOI: 10.1021/acs.jmedchem.3c01303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 31.08.2023. Verfasst von Yichen Tong und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Sun Yat-sen University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Synucleinopathies. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD) confers knockdown of "undruggable" targets such as alpha-synuclein (αSyn), a pathogenic protein in multiple neurodegenerative diseases. Though many of these proteins were mainly degraded through the autophagy-lysosome pathway (ALP), few TPD tools harnessing the ALP were reported. Herein, we developed a strategy termed autophagosome-anchoring chimera (ATACC), in which the protein of interest (POI) can be anchored to microtubule-associated protein-1 light chain-3B (LC3B) on the autophagosome with the assistance of an LC3-interacting region (LIR)-containing bifunctional peptide, and the selective autophagy of the POI is thus facilitated. A series of αSyn-targeting ATACC peptides were designed and synthesized. Biological evaluations demonstrated that these compounds could degrade αSyn specifically and effectively through a "chemical-induced cargo recognition-ALP degradation" mechanism. The neuroprotective effects of ATACC peptide P1 were further validated in vitro and in vivo. Collectively, our results provided a new TPD tool and revealed a potential therapeutic strategy against synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinSynucleinopathiesHumansAutophagosomesPeptidesAutophagy

Substanzen

alpha-SynucleinPeptides

Autor:innen und Institutionen

  • School of Chemistry, Sun Yat-sen University, Guangzhou 510006, China.
  • International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE) & Guangzhou City Key Laboratory of Precision Chemical Drug Develo…

ORCID-Profile: Yichen Tong, Wentao Zhu, Fang Xu, Jiyan Pang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Tong, Y., Zhu, W., Chen, J., Zhang, W., Xu, F., & Pang, J. (2023). Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides. Journal of Medicinal Chemistry, 66(17), 12614-12628. https://doi.org/10.1021/acs.jmedchem.3c01303

Vancouver

Tong Y, Zhu W, Chen J, Zhang W, Xu F, Pang J. Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides. Journal of Medicinal Chemistry. 2023;66(17):12614-12628. doi:10.1021/acs.jmedchem.3c01303

BibTeX
@article{Tong2023,
  author = {Tong, Yichen and Zhu, Wentao and Chen, Jian and Zhang, Wenqian and Xu, Fang and Pang, Jiyan},
  title = {Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {17},
  pages = {12614--12628},
  doi = {10.1021/acs.jmedchem.3c01303}
}
Kostenlos starten →